Scientists from MedUni Vienna have now successfully developed a technique for suctioning the IgE antibodies out of the blood, thereby significantly
improving the quality of life for people who suffer from
severe allergic
asthma.
«This research is an attempt to better understand the immunology of patients with
severe asthma and to answer the question of why they don't
improve when taking corticosteroids,» said Bruce Levy, MD, chief of the Division of Pulmonary and Critical Care Medicine at BWH.
For the study, conducted as part of the doctoral thesis of Mahesh Raundhal, a graduate student in the laboratory of Prabir Ray, Ph.D., Pitt professor of medicine and co-senior author, the research team examined lung cell samples obtained from patients also participating in the
Severe Asthma Research Program (SARP), a National Heart, Lung, and Blood Institute of the National Institutes of Health - sponsored program to improve the understanding of severe a
Severe Asthma Research Program (SARP), a National Heart, Lung, and Blood Institute of the National Institutes of Health - sponsored program to improve the understanding of severe a
Asthma Research Program (SARP), a National Heart, Lung, and Blood Institute of the National Institutes of Health - sponsored program to
improve the understanding of
severe a
severe asthmaasthma.
«Recent clinical trials in
severe asthma patients using antibodies that block IL4Ra have shown positive results leading to marked improvement of lung function,
improved symptoms and reduced use of oral steroids,» Professor Anderson said.